Allmed Solutions Ltd (ALMD) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Allmed Solutions Ltd (ALMD) has a cash flow conversion efficiency ratio of -0.241x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-6.77 Million ≈ $-18.14K USD) by net assets (ILA28.07 Million ≈ $75.25K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Allmed Solutions Ltd balance sheet independence to measure how much of total assets are equity-financed.
Allmed Solutions Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Allmed Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check ALMD operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Allmed Solutions Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allmed Solutions Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Aumake Ltd
AU:AUK
|
0.022x |
|
Alice QUEEN Ltd
AU:AQX
|
5.144x |
|
Newbury Pharmaceuticals AB
ST:NEWBRY
|
0.072x |
|
Shanghai Broadband Technology Co Ltd
SHG:600608
|
0.540x |
|
RS Public Company Limited
BK:RS
|
-0.051x |
|
Pharmacielo Ltd
V:PCLO
|
0.236x |
|
Intanwijaya Internasional Tbk
JK:INCI
|
0.079x |
|
Amtel Holdings Bhd
KLSE:7031
|
-0.019x |
Annual Cash Flow Conversion Efficiency for Allmed Solutions Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Allmed Solutions Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see ALMD stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ILA28.07 Million ≈ $75.25K |
ILA-12.08 Million ≈ $-32.39K |
-0.430x | -125.38% |
| 2024-12-31 | ILA42.02 Million ≈ $112.65K |
ILA-8.03 Million ≈ $-21.51K |
-0.191x | -249.81% |
| 2023-12-31 | ILA55.97 Million ≈ $150.06K |
ILA7.14 Million ≈ $19.13K |
0.127x | +167.35% |
| 2022-12-31 | ILA53.96 Million ≈ $144.67K |
ILA-10.21 Million ≈ $-27.39K |
-0.189x | -80.81% |
| 2021-12-31 | ILA52.31 Million ≈ $140.25K |
ILA-5.48 Million ≈ $-14.68K |
-0.105x | +42.08% |
| 2020-12-31 | ILA48.77 Million ≈ $130.76K |
ILA-8.82 Million ≈ $-23.64K |
-0.181x | +17.04% |
| 2019-12-31 | ILA56.58 Million ≈ $151.69K |
ILA-12.33 Million ≈ $-33.05K |
-0.218x | +55.35% |
| 2018-12-31 | ILA32.83 Million ≈ $88.02K |
ILA-16.02 Million ≈ $-42.96K |
-0.488x | -2.71% |
| 2017-12-31 | ILA38.76 Million ≈ $103.91K |
ILA-18.42 Million ≈ $-49.38K |
-0.475x | -5.08% |
| 2016-12-31 | ILA38.19 Million ≈ $102.39K |
ILA-17.27 Million ≈ $-46.30K |
-0.452x | -28.55% |
| 2015-12-31 | ILA45.13 Million ≈ $120.98K |
ILA-15.87 Million ≈ $-42.56K |
-0.352x | +40.54% |
| 2014-12-31 | ILA32.16 Million ≈ $86.22K |
ILA-19.03 Million ≈ $-51.01K |
-0.592x | -33.36% |
| 2013-12-31 | ILA30.22 Million ≈ $81.02K |
ILA-13.41 Million ≈ $-35.94K |
-0.444x | -1.62% |
| 2012-12-31 | ILA67.29 Million ≈ $180.40K |
ILA-29.37 Million ≈ $-78.75K |
-0.437x | -141.17% |
| 2011-12-31 | ILA72.36 Million ≈ $193.98K |
ILA-13.10 Million ≈ $-35.11K |
-0.181x | +43.58% |
| 2010-12-31 | ILA26.29 Million ≈ $70.47K |
ILA-8.43 Million ≈ $-22.61K |
-0.321x | -102.04% |
| 2009-12-31 | ILA10.83 Million ≈ $29.04K |
ILA-1.72 Million ≈ $-4.61K |
-0.159x | +61.70% |
| 2008-12-31 | ILA14.19 Million ≈ $38.04K |
ILA-5.88 Million ≈ $-15.77K |
-0.415x | -- |
About Allmed Solutions Ltd
Allmed Solutions Ltd develops, manufactures, and markets minimally invasive products in various medical disciplines in Israel and internationally. The company offers drugs, biological products, and medical devices; and ProCatid system, a distal embolic protection system comprised of an independent filter unit that can be delivered, locked, and deployed on any commercially marketed guide wires. It… Read more